Why Cell Therapeutics Inc. Shares Jumped

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Cell Therapeutics (NASDAQ: CTIC  ) , an acquirer and developer of cancer-focused therapies, jumped as much as 22% following a positive final appraisal determination from the National Institute for Health and Care Excellence, or NICE, regarding Pixuvri.

So what: According to Cell Therapeutics' press release, NICE determined that Pixuvri, a treatment for multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma, was deemed cost effective, meaning physicians in the United Kingdom will soon have access to the drug as a third or fourth-line treatment option for patients. Cell Therapeutics anticipates launching Pixuvri in England sometime in the early spring following the publication of the final appraisal determination.

Now what: There's no way to spin this as anything but good news for Cell Therapeutics, but given it's long-winded history of destroying shareholder value you'll forgive me if I don't break out my pompons. Pixuvri alone isn't going to be enough to turn CTI profitable, so it'll still need to work diligently to develop its pipeline of cancer therapies. This is finally a step in the right direction for CTI, but it has a long way to go before being a viable investment opportunity in my eyes.

This company's growth potential could blow Cell Therapeutics out of the water!
Opportunities to get wealthy from a single investment don't come around often, but they do exist, and our chief technology officer believes he's found one. In this free report, Jeremy Phillips shares the single company that he believes could transform not only your portfolio, but your entire life. To learn the identity of this stock for free and see why Jeremy is putting more than $100,000 of his own money into it, all you have to do is click here now.


Read/Post Comments (2) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 07, 2014, at 9:36 AM, Jibo999 wrote:

    This is a "wisest" comment on CTIC I have ever read. I know - Fool doesn't like CTIC, but enough is enough. This is Fool's another attempt to turn good news into a bad news:)

  • Report this Comment On January 07, 2014, at 9:50 AM, Jibo999 wrote:

    Compare to any other biopharmaceutical companies CTI is doing extremely well at this moment. For additional news please visit company website at:

    http://www.celltherapeutics.com

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2784768, ~/Articles/ArticleHandler.aspx, 8/21/2014 4:18:02 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement